Mechanistically, RANKL/RANK can rapidly alter mitochondrial respiration in primary mouse KRasG12D mutant pneumocytes and in lung cancer cells, which at least in part could be explained by the marked induction of PGC1β expression. Here, PPARGC1B is linked to lung cancer.